Article
Intratumoral heterogeneity of intrahepatic cholangiocarcinoma.
Oncotarget - 28 Feb 2017
Walter Dirk, Döring Claudia, Feldhahn Magdalena, Battke Florian, Hartmann Sylvia, Winkelmann Ria, Schneider Markus, Bankov Katrin, Schnitzbauer Andreas, Zeuzem Stefan, Hansmann Martin Leo, Peveling-Oberhag Jan
Abstract excerpt
No personalized therapy regimens could demonstrate a benefit in survival of intrahepatic cholangiocarcinoma (iCCA). Since genetic heterogeneity might influence single biopsy based targeted therapy or the outcome of clinical trials, aim of the present study was to investigate intratumoral heterogeneity of iCCA by whole exome sequencing. Therefore, samples from tumor center and tumor periphery of large iCCA lesions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
